Development of a Next-Generation Immunoprevention Platform Against HIV-1
Award Notice Posted
- Solicitation number
- PHS-2024-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Neovaxsyn Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93024C00050 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Ames, Iowa 50011, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services' National Institute of Allergy and Infectious Diseases awarded a $300,000 contract to NEOVAXSYN INC on August 1, 2024 for the Development of a Next-Generation Immunoprevention Platform Against HIV-1. This award falls under the Total Small Business set-aside category.
Notice text
Awarded contract 75N93024C00050 to NEOVAXSYN INC for 300000.00 on 2024-08-01.
Notice history
6 of 9 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity